CopyMark Law Group
4.9/5
Drawing for IMMUNOPD

USPTO serial 99943864

IMMUNOPD

Reviewed by CopyMark Law Group

Status 630
Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with IMMUNOPD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman Wilson Sonsini Goodrich & Rosati650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for analyzing blood samples to assess gene expression signatures and molecular biomarkers for the detection of disease, monitoring of disease status, and evaluation of patient response to therapeutic treatment; in vitro diagnostic reagents for detecting disease-associated molecular biomarkers in blood samplesACTIVE—
044Medical and clinical diagnostic and prognostic testing services for laboratory analysis of blood samples to assess gene expression signatures and molecular biomarkers for the detection of disease, monitoring of disease status, and evaluation of patient responses to therapeutic treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 16, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance